Research Article
Clinical Efficacy of Antianlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small-Cell Lung Cancer and Its Effect on Serum VEGF, CEA, and SCC-Ag
Figure 2
Changes in the levels of T lymphocyte subsets. # vs. before treatment.
(a) |
(b) |
(c) |
(d) |